PMGC Holdings, Inc. (ELAB)
4.20
-0.74
(-14.98%)
USD |
NASDAQ |
Dec 09, 13:05
PMGC Holdings EPS Diluted (Quarterly): -4.909 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.616M |
| Revenue (Quarterly) | 0.2859M |
| Total Expenses (Quarterly) | 2.902M |
| Enterprise Value | -0.4191M |
| Gross Profit Margin (Quarterly) | 14.94% |
| Profit Margin (Quarterly) | -915.0% |
| Earnings Yield | -8.13K% |
| Normalized Earnings Yield | -8373.87 |